Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124829142 | 12482914 | 2 | F | 20160809 | 20160620 | 20160812 | EXP | PHEH2016US015063 | NOVARTIS | 0.00 | F | Y | 98.80000 | KG | 20160812 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124829142 | 12482914 | 1 | SS | LETROZOL | LETROZOLE | 1 | Unknown | 2.5 MG, UNK | 0 | 2.5 | MG | ||||||||
| 124829142 | 12482914 | 2 | SS | FEMARA | LETROZOLE | 1 | Oral | 2.5 MG, QD (DAILY) | 0 | 2.5 | MG | TABLET | QD | ||||||
| 124829142 | 12482914 | 3 | PS | ZOMETA | ZOLEDRONIC ACID | 1 | Unknown | QMO (MONTHLY) | 21223 | /month | |||||||||
| 124829142 | 12482914 | 4 | C | ASPIRIN /00346701/ | ASCORBIC ACIDASPIRIN | 1 | Unknown | U | 0 | ||||||||||
| 124829142 | 12482914 | 5 | C | ENDOCET | ACETAMINOPHENOXYCODONE HYDROCHLORIDE | 1 | Unknown | U | 0 | ||||||||||
| 124829142 | 12482914 | 6 | C | METOPROLOL TARTRATE. | METOPROLOL TARTRATE | 1 | Unknown | U | 0 | ||||||||||
| 124829142 | 12482914 | 7 | C | STOOL SOFTENER | DOCUSATE CALCIUM | 1 | Unknown | U | 0 | ||||||||||
| 124829142 | 12482914 | 8 | C | TRAZODONE | TRAZODONE HYDROCHLORIDE | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124829142 | 12482914 | 1 | Product used for unknown indication |
| 124829142 | 12482914 | 2 | Product used for unknown indication |
| 124829142 | 12482914 | 3 | Product used for unknown indication |
| 124829142 | 12482914 | 4 | Product used for unknown indication |
| 124829142 | 12482914 | 5 | Product used for unknown indication |
| 124829142 | 12482914 | 6 | Product used for unknown indication |
| 124829142 | 12482914 | 7 | Product used for unknown indication |
| 124829142 | 12482914 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124829142 | 12482914 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124829142 | 12482914 | Abdominal pain | |
| 124829142 | 12482914 | Blood glucose increased | |
| 124829142 | 12482914 | Cough | |
| 124829142 | 12482914 | Haematocrit decreased | |
| 124829142 | 12482914 | Lymphoedema | |
| 124829142 | 12482914 | Mean cell volume abnormal | |
| 124829142 | 12482914 | Pain in extremity | |
| 124829142 | 12482914 | Peripheral swelling | |
| 124829142 | 12482914 | Sleep disorder | |
| 124829142 | 12482914 | Thrombosis | |
| 124829142 | 12482914 | Transient ischaemic attack |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124829142 | 12482914 | 1 | 20150817 | 0 | ||
| 124829142 | 12482914 | 2 | 201507 | 0 |